StocksMediumUpdated•Originally published 13 November 2026•Updated 13 November 2026•
1 min read
Immunic Shares Drop 5% as Administrative Expenses Surge in Q3
Key Facts
1Immunic reported a GAAP EPS of -$0.99, missing analyst estimates by $0.04.
Immunic shares fell 5% after the company reported a third-quarter GAAP loss of $0.99 per share, missing analyst estimates by $0.04. Seeking Alpha reported that the financial results showed a wider loss than the market consensus had anticipated.
General and administrative expenses rose to $19.4 million from $6 million a year earlier, contributing to the quarterly net loss. IMUX was trading at $7.40 on November 13, 2026, following the decline; the company held $132.0 million in cash as of September 30, 2026, which is expected to fund operations into late 2027.